ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Scottish startup 1nhaler secured 2.2 million pounds in follow-on funding to advance its cardboard inhaler technology. The investment from Archangels, Scottish Enterprise, and BBB Investments supports late-stage development of 1nhaler Salbutamol, targeting regulatory approval by late 2027.
Tap to vote and see what everyone thinks.
Summary by ByteBrief